10 Best Momentum Stocks to Buy According to Hedge Funds

8. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 92

Boston Scientific Corporation (NYSE:BSX) is a global leader in the development of medical devices that are used to treat a wide range of medical conditions. With a strong focus on innovation, the company offers solutions across various therapeutic areas, including cardiology, endoscopy, urology, and neuromodulation. In the past 12 months, the stock has surged by nearly 61%, which makes it one of the best momentum stocks.

Boston Scientific Corporation (NYSE:BSX) continues to make significant strides in expanding its product portfolio and enhancing its market position through strategic initiatives. In January 2025, the company made waves by announcing its acquisition of Bolt Medical, Inc., a move designed to strengthen its cardiovascular offerings and address critical heart conditions like coronary and peripheral artery diseases. Alongside acquisitions, Boston Scientific Corporation (NYSE:BSX) is advancing its clinical trials, notably with the FARAPULSE™ Pulsed Field Ablation System, which has shown promising results in the ADVANTAGE AF trial for atrial fibrillation.

Boston Scientific Corporation (NYSE:BSX) reported fourth quarter and full year 2024 financials on Feb 5, 2025. The company generated $4.561 billion in net sales for Q4, a 22.4% increase year-over-year. For the full year, it delivered $16.747 billion in net sales, reflecting a 17.6% growth, while its adjusted EPS rose to $2.51, up from $2.05 in 2023. Notably, the company’s Cardiovascular segment saw exceptional growth, with organic sales up 27.4%.

According to the Insider Monkey Q3 2024 hedge fund database, 92 hedge funds held positions in Boston Scientific Corporation (NYSE:BSX).